CFO transition
QuidelOrtho Corporation CFO transition: Micah Young to succeed Joseph M. Busky
QuidelOrtho Corporation reported in a Form 8-K filed June 23, 2026 that Micah Young will succeed Joseph M. Busky as Chief Financial Officer and principal financial officer, effective July 6, 2026.
In the filing's words
The Board of Directors of QuidelOrtho Corporation (the “Company”) has appointed Micah Young to serve as the Company’s Chief Financial Officer and principal financial officer, effective as of July 6, 2026 (the “Effective Date”).
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | QuidelOrtho Corporation (QDEL) |
|---|---|
| Event | Transition |
| Incoming | Micah Young |
| Outgoing | Joseph M. Busky |
| Title in the filing | Chief Financial Officer and principal financial officer |
| Effective | July 6, 2026 |
| 8-K filed | June 23, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Executive Vice President and Chief Financial Officer, Masimo Corporation |
| SEC CIK | 0001906324 |
QuidelOrtho Corporation reported this change in a Form 8-K, Item 5.02, filed June 23, 2026. The filing's own words are quoted above.
Other records naming Joseph M. Busky
1The outgoing officer on this record, matched by name. Career line.
2026-02-19 · 10-K signature
Joseph M. Busky signed QuidelOrtho Corp's annual report as Chief Financial Officer (Principal Financial and Accounting Officer)
Also filed in June 2026
Other CFO moves on the record that month. All moves.
4 months ago· 2026-06-30TransitionBANX
ArrowMark Financial Corp. CFO transition: Katherine Jones to succeed Patrick Farrell
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
4 months ago· 2026-06-29TransitionGCO
Genesco Inc. CFO transition: Jonathan Collins to succeed Mimi E. Vaughn
4 months ago· 2026-06-29TransitionTNYA
Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Micah Young? Send a correction with the primary source.